
1. malar j. 2016 oct 18;15(1):501.

size polymorphism low sequence diversity locus encoding plasmodium
vivax rhoptry neck protein 4 (pvron4) colombian isolates.

buitrago sp(1)(2), garzón-ospina d(1)(3), patarroyo ma(4)(5).

author information: 
(1)fundación instituto de inmunología de colombia (fidic), carrera 50 no. 26-20, 
bogotá d.c., colombia.
(2)microbiology postgraduate program, universidad nacional de colombia, bogotá
d.c., colombia.
(3)school medicine health sciences, universidad del rosario, bogotá d.c., 
colombia.
(4)fundación instituto de inmunología de colombia (fidic), carrera 50 no. 26-20, 
bogotá d.c., colombia. mapatarr.fidic@gmail.com.
(5)school medicine health sciences, universidad del rosario, bogotá d.c., 
colombia. mapatarr.fidic@gmail.com.

background: designing vaccine plasmodium vivax focused selecting
antigens involved invasion mechanisms must domains low
polymorphism avoiding allele-specific immune responses. rhoptry neck
protein 4 (ron4) forms part tight junction, essential the
invasion hepatocytes and/or erythrocytes; however, little known 
locus' genetic diversity.
methods: dna sequences 73 colombian clinical isolates pvron4 gene 
analysed characterizing genetic diversity; pvron4 haplotype number 
distribution, well evolutionary forces determining diversity pattern,
were assessed population genetics molecular evolutionary approaches.
results: ron4 has low genetic diversity p. vivax sequence level; however, a
variable amount tandem repeats n-terminal region leads extensive
size polymorphism. region seems exposed immune system. the
central region putative esterase/lipase domain which, like protein's
c-terminal fragment, highly conserved intra- inter-species level. 
regions purifying selection.
conclusions: pvron4 is locus lowest genetic diversity described to
date p. vivax. repeat regions n-terminal region could be
associated immune evasion mechanisms central region the
c-terminal region seem functional structural constraint. bearing
such results mind, pvron4 central and/or c-terminal portions represent
promising candidates designing subunit-based vaccine aimed 
avoiding allele-specific immune response, might limit vaccine efficacy.

doi: 10.1186/s12936-016-1563-4 
pmcid: pmc5069803
pmid: 27756311  [indexed medline]

